Regulators flag possible birth defect link to GSK's HIV drug

LONDON (Reuters) - U.S. and European regulators said they were assessing evidence that GlaxoSmithKline's HIV drug dolutegravir might be linked to serious birth defects, casting a shadow over a medicine that has been a key profit driver in recent years.

from Reuters: Top News http://uk.reuters.com/article/uk-gsk-hiv-defects/regulators-flag-possible-birth-defect-link-to-gsks-hiv-drug-idUKKCN1IJ1YZ?feedType=RSS&feedName=topNews